SPAC4F10.19c Antibody

What is the SPAC4F10.19c protein and why is it studied?

SPAC4F10.19c is an uncharacterized zinc-finger protein in Schizosaccharomyces pombe (strain 972/24843), commonly known as fission yeast. As a zf-HIT protein Hit1 (predicted), it is part of an important family of zinc-finger proteins that likely play roles in gene regulation, DNA binding, or protein-protein interactions. Research on this protein contributes to our understanding of fundamental cellular processes in eukaryotic organisms, particularly those related to gene expression regulation in fungi. The protein has gained scientific interest due to its conservation across fungal species and potential role in cell wall integrity pathways, which are critical for fungal growth and development .

What types of SPAC4F10.19c antibodies are currently available for research?

Current research resources include polyclonal antibodies raised in rabbits against the SPAC4F10.19c protein of Schizosaccharomyces pombe. These antibodies are primarily designed for applications such as ELISA (Enzyme-Linked Immunosorbent Assay) and Western blot analysis. The antibodies are generally purified using antigen-affinity methods, ensuring specificity for the target protein . Additionally, recombinant SPAC4F10.19c protein is available with greater than 85% purity as determined by SDS-PAGE, which can be useful as a positive control in experiments or for raising custom antibodies .

How is the specificity of SPAC4F10.19c antibodies validated?

The validation of SPAC4F10.19c antibodies typically involves multiple methodological approaches:

• Western blot analysis: Demonstrating specific binding to the target protein at the expected molecular weight in yeast cell lysates.

• Immunoprecipitation: Confirming the antibody's ability to pull down the target protein.

• Cross-reactivity testing: Evaluating potential cross-reactivity with related proteins.

• Cell wall biotinylation: A specialized technique to verify the antibody's ability to detect cell wall-associated proteins .

• SDS-PAGE analysis: Confirming purity and specificity through gel electrophoresis.

For optimal validation, researchers should include both positive controls (S. pombe extracts) and negative controls (lysates from organisms not expressing SPAC4F10.19c) .

What are the recommended protocols for using SPAC4F10.19c antibodies in Western blot analysis?

When using SPAC4F10.19c antibodies for Western blot applications, researchers should consider the following optimized protocol:

Sample Preparation:

• Harvest S. pombe cells in mid-log phase (OD600 of 0.5-0.8)

• Perform spheroplasting using standardized protocols with zymolyase

• Extract proteins using a buffer containing appropriate protease inhibitors

• Determine protein concentration (e.g., BCA assay)

Western Blot Protocol:

• Separate proteins on 10-12% SDS-PAGE gels

• Transfer to PVDF or nitrocellulose membranes

• Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with anti-SPAC4F10.19c antibody (recommended dilution: 1:1000) overnight at 4°C

• Wash with TBST (3 × 10 minutes)

• Incubate with HRP-conjugated secondary antibody (1:5000) for 1 hour

• Wash with TBST (3 × 10 minutes)

• Detect using ECL substrate

Expected results: A specific band corresponding to SPAC4F10.19c protein (approximately 35-40 kDa, depending on post-translational modifications) .

How can SPAC4F10.19c antibodies be used to study protein localization?

For protein localization studies, researchers can employ the following approaches:

Immunofluorescence Protocol:

• Fix S. pombe cells with 4% paraformaldehyde for 30 minutes

• Permeabilize with 0.1% Triton X-100 for 10 minutes

• Block with 5% BSA for 1 hour

• Incubate with anti-SPAC4F10.19c antibody (1:200 dilution) overnight at 4°C

• Wash with PBS (3 × 5 minutes)

• Incubate with fluorescently-labeled secondary antibody for 1 hour

• Counterstain with DAPI for nuclear visualization

• Mount and image using confocal microscopy

Subcellular Fractionation:
Combine with Western blot analysis of different cellular fractions (cytosolic, nuclear, membrane, and cell wall) to determine the predominant localization of SPAC4F10.19c. Research suggests that as a potential cell wall-related protein, it may be found in association with the cell wall or Golgi apparatus .

What techniques can be used to study SPAC4F10.19c function in S. pombe?

Several complementary approaches can be employed to characterize SPAC4F10.19c function:

Gene Deletion/Conditional Expression:

• Create a sup11+ (SPAC4F10.19c homolog) deletion or conditional expression strain

• Analyze growth phenotypes under various conditions

• Evaluate cell wall integrity using sensitivity to cell wall-perturbing agents (e.g., Calcofluor White, Congo Red)

Protein-Protein Interaction Studies:

• Co-immunoprecipitation using anti-SPAC4F10.19c antibody

• Yeast two-hybrid screening

• Proximity-based labeling techniques (BioID or APEX)

Transcriptome Analysis:
Microarray or RNA-seq analysis of wild-type vs. SPAC4F10.19c mutant strains can reveal regulated genes and affected pathways. Previous studies of related proteins indicate significant regulation of cell wall glucan-modifying enzymes .

How does SPAC4F10.19c contribute to cell wall integrity in S. pombe?

Based on studies of homologous proteins, SPAC4F10.19c (Sup11p) appears to be essential for cell wall integrity in S. pombe. Research data indicates:

• β-1,6-Glucan Synthesis: SPAC4F10.19c is critical for β-1,6-glucan formation, a key structural component of the fungal cell wall.

• Septum Formation: Depletion leads to malformation of the septum with accumulation of cell wall material.

• Cellular Morphology: Mutants show severe morphological defects.

• Transcriptional Regulation: SPAC4F10.19c depletion induces significant cell wall remodeling processes, affecting the expression of multiple glucanases and glucan-modifying enzymes .

The following table summarizes the cell wall composition changes observed in conditional SPAC4F10.19c (Sup11p) mutants:

What are the challenges in detecting SPAC4F10.19c protein and how can they be overcome?

Detection of SPAC4F10.19c presents several challenges that researchers should address:

Challenge 1: Low Expression Levels

• Solution: Use enrichment techniques such as immunoprecipitation before Western blot analysis

• Alternative: Employ more sensitive detection methods like chemiluminescent substrates with longer exposure times

Challenge 2: Cross-Reactivity with Related Proteins

• Solution: Pre-absorb antibodies with closely related proteins or lysates from knockout strains

• Alternative: Use epitope-tagged versions of SPAC4F10.19c for cleaner detection

Challenge 3: Post-translational Modifications

• Solution: Treat samples with appropriate enzymes (e.g., EndoH for N-glycosylation, phosphatases for phosphorylation)

• Alternative: Use multiple antibodies targeting different epitopes of the protein

Challenge 4: Protein Localization in Cell Wall

• Solution: Employ specialized extraction protocols with cell wall-digesting enzymes

• Alternative: Use cell wall biotinylation techniques to specifically label and identify surface-exposed proteins

How can active learning approaches improve antibody-antigen binding prediction for SPAC4F10.19c research?

Recent advancements in active learning methodologies can enhance antibody research related to SPAC4F10.19c:

• Library-on-Library Approaches: These techniques can identify specific interacting pairs between many antibodies and various SPAC4F10.19c epitopes or mutants.

• Machine Learning Models: These can predict binding by analyzing many-to-many relationships between antibodies and antigens, including challenging out-of-distribution predictions.

• Cost Reduction Strategies: Active learning starts with a small labeled subset of data and iteratively expands the labeled dataset, making comprehensive antibody development more feasible.

Research has shown that optimized active learning algorithms can reduce the number of required antigen mutant variants by up to 35% and accelerate the learning process significantly compared to random baseline approaches .

What is the relationship between SPAC4F10.19c glycosylation and antibody recognition?

SPAC4F10.19c (Sup11p) undergoes post-translational modifications, including glycosylation, which can affect antibody recognition. Key findings include:

• O-mannosylation: Sup11p appears to be an O-mannoprotein, with multiple potential O-glycosylation sites in S/T-rich regions.

• N-glycosylation: Unusual N-glycosylation can occur on an N-X-A sequon when expressed in certain O-mannosylation mutant backgrounds.

• Glycosylation Masking: Highly O-mannosylated regions may mask potential N-glycosylation sites in wild-type conditions.

• Impact on Antibody Binding: Different glycosylation states can significantly alter epitope accessibility and antibody recognition .

For optimal antibody development and application, researchers should consider these glycosylation patterns and potentially develop antibodies that target non-glycosylated regions or that specifically recognize certain glycoforms.

What controls should be included when using SPAC4F10.19c antibodies for experimental validation?

To ensure reliable and reproducible results, the following controls should be implemented:

Positive Controls:

• Recombinant SPAC4F10.19c protein (≥85% purity) for Western blot or ELISA calibration

• Wild-type S. pombe cell lysates expressing endogenous SPAC4F10.19c

• Overexpression systems with tagged SPAC4F10.19c

Negative Controls:

• SPAC4F10.19c knockout or knockdown S. pombe strains

• Lysates from unrelated organisms (e.g., E. coli or mammalian cells)

• Primary antibody omission control

Specificity Controls:

• Pre-adsorption of antibody with recombinant antigen

• Isotype control antibodies (same host species and isotype)

• Cross-reactivity assessment with related proteins

How should researchers interpret conflicting results when using SPAC4F10.19c antibodies?

When faced with contradictory findings using SPAC4F10.19c antibodies, consider this systematic approach:

• Verify antibody quality: Check for degradation, aggregation, or contamination through analytical methods like SDS-PAGE.

• Examine experimental conditions: Subtle variations in buffers, temperatures, or incubation times can significantly impact antibody performance.

• Consider post-translational modifications: Different extraction methods may preserve or disrupt various PTMs on SPAC4F10.19c, affecting antibody recognition.

• Evaluate protein conformation: Native vs. denatured conditions can reveal epitope accessibility issues.

• Cross-validate using orthogonal methods: Combine antibody-based detection with mass spectrometry or genetic approaches to confirm observations.

A decision tree for resolving conflicting results might include:

• First, verify antibody specificity using knockdown controls

• Next, examine sample preparation methods for possible artifacts

• Then, consider alternative antibodies targeting different epitopes

• Finally, implement complementary non-antibody-based approaches

How can researchers enhance the specificity of SPAC4F10.19c antibody detection in mixed samples?

For complex samples containing multiple proteins that may cross-react, consider these approaches:

• Epitope mapping and antibody selection: Identify unique epitopes of SPAC4F10.19c not shared with related proteins.

• Pre-absorption strategies: Incubate antibodies with lysates from organisms lacking SPAC4F10.19c to remove cross-reactive antibodies.

• Two-dimensional analysis: Combine isoelectric focusing with SDS-PAGE to better separate proteins with similar molecular weights.

• Affinity purification of target protein: Use tagged versions of SPAC4F10.19c or immunoprecipitation to enrich the target before analysis.

• Competitive binding assays: Develop assays similar to those used for other antibodies, where binding is assessed through competition with well-characterized antibodies of known specificity .

How can newly developed high-throughput antibody screening methods be applied to SPAC4F10.19c research?

Modern antibody screening technologies offer promising avenues for SPAC4F10.19c research:

• Single-cell RNA and VDJ sequencing: This approach can rapidly identify high-affinity antibodies from immunized subjects, similar to methods used for developing antibodies against bacterial proteins like SpA5 .

• Cell-based Spike-ACE2 inhibition assay adaptations: Modified versions of these assays could assess the functional activity of anti-SPAC4F10.19c antibodies in cellular contexts .

• Microarray hybridization techniques: These allow for transcriptome analysis of mutants, providing insights into cellular responses to SPAC4F10.19c depletion or modification .

• Cell-based mutated protein assays: Similar to those used for coronavirus research, these could identify critical epitopes and interaction domains of SPAC4F10.19c .

What are the implications of SPAC4F10.19c research for understanding broader fungal cell biology?

SPAC4F10.19c research extends beyond the specific protein to illuminate key aspects of fungal biology:

• Evolutionary conservation: SPAC4F10.19c shows homology to S. cerevisiae Kre9, suggesting conserved functions in β-1,6-glucan synthesis across fungal species.

• Cell wall architecture: Studies reveal critical roles in maintaining cell wall integrity, with implications for understanding fungal cell wall assembly and dynamics.

• Septum formation: Research indicates essential functions in septum assembly, providing insights into fungal cell division mechanisms.

• Protein glycosylation pathways: Investigation of SPAC4F10.19c offers perspectives on the interplay between O-mannosylation and N-glycosylation in fungi .

These findings contribute to our fundamental understanding of eukaryotic cell biology while potentially informing antifungal drug development strategies targeting cell wall biosynthesis pathways.